Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-02-24

Clinical Trial Update: Comparison of the Panax Ginseng + Associations to Ginkgo Biloba in the Treatment of Cognitive Function Disorders [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Panax Ginseng+ associations to Ginkgo Biloba for cognitive function disorders was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginkgo biloba (Ginkgo biloba)
  • Panax Ginseng + Associations

Snippet

Sponsor: EMS | Conditions: Memory Deficit | Phase 3 | Status: WITHDRAWN